Barely Significant
← all excerpts

Bone-targeted therapies to reduce skeletal morbidity in prostate cancer.

Asian J Androl · 2018 · PMC5952474 · PMID 29553053

Europe PMCDOI
1
hedged sentence
0.0540
closest p · 1.1× alpha
0.0540
boldest claim

The sentences

nearly significantP = 0.054so close (0.05 < p ≤ 0.1)
However, the subset of men with prior SRE had a nearly significant reduction in second SRE, median 31.9 months for zoledronic acid compared to 17.6 months for placebo, P = 0.054.

also in 3,287 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.